Literature DB >> 32305630

A severe case with co-infection of SARS-CoV-2 and common respiratory pathogens.

Xueting Ou1, Liyang Zhou1, Huanliang Huang2, Yuebao Lin3, Xingfei Pan4, Dexiong Chen5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32305630      PMCID: PMC7161507          DOI: 10.1016/j.tmaid.2020.101672

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


× No keyword cloud information.
To the Editor Since December, 2019, corona virus disease 2019 (COVID-19) caused by SARS-CoV-2, has spread to the majority of countries worldwide [1,2]. Here, we reported the clinical characteristics of a severe case with co-infection of SARS-CoV-2 and common respiratory pathogens. The patient was a 65-year-old woman, who had severe clinical manifestations of COVID-19, including symptoms, decreased lymphocyte counts, abnormal chest CT images. Next-generations sequencing (NGS) was used to test whether she was co-infected with other pathogens besides SARS-CoV-2. The sputum samples were collected and found the presence of Haemophilus parainfluenzae and Moraxella catarrhalis by NGS. On Jan 22, 2020, she travelled from Wuhan to Guangzhou, China by high speed rail. From Feb 11, she developed fever lasted for 9 days, and developed cough as well as sore throat, without chills, headache, arthralgia, myalgia. On Feb 20, she was transferred to the Third Affiliated Hospital of Guangzhou Medical University with a body temperature of 38 °C. The next day, she developed a bit shortness of breath, with a body temperature of 37.5 °C. On Feb 21, blood routine tests showed normal white blood cell counts, but decreased lymphocyte counts. The blood glucose was increased. Chest CT scans showed bilateral diffuse ground-glass opacities and consolidation (Fig. 1 ). Nasopharyngeal swab samples were collected twice and both were negative for SARS-CoV-2 tested by qRT-PCR. However, sputum samples collected on the same day were positive for SARS-CoV-2 by NGS. Furthermore, Haemophilus parainfluenzae and Moraxella catarrhalis were also found in the sputum samples by NGS. In the afternoon of the same day, the oxygen saturation values of the patient decreased to 91.2%, and the partial pressure of oxygen in arterial blood decreased to 61.2 mmHg. Therefore, she received high-flow nasal cannula oxygen therapy (40% concentration, flow rate 60 L/min). The patient was diagnosed as severe COVID-19, and was transferred to the First Affiliated Hospital of Guangzhou Medical University for isolation and treatment where are designed to treat severe COVID-19 cases by local health authorities.
Fig. 1

Chest CT images of the Patient. CT scans showed bilateral multiple lobular and subsegmental areas of ground-glass opacity and consolidation 9 days after symptoms onset.

Chest CT images of the Patient. CT scans showed bilateral multiple lobular and subsegmental areas of ground-glass opacity and consolidation 9 days after symptoms onset. More and more COVID-19 cases have been reported by the majority of countries worldwide [2]. Health-care professionals do their best to treat patients with COVID-19. Unfortunately, 85,522 cases died of COVID-19 globally by April 9, 2020 [2]. This implies that we need further to improve how to treat COVID-19, especially for severe cases. In the present study, the cause that resulted in severe condition of the patient could be the co-infection of SARS-CoV-2, Haemophilus parainfluenzae and Moraxella catarrhalis. Nowadays, more attentions are paid to SARS-CoV-2, so it is easy to neglect patients infected with other pathogens besides SARS-CoV-2 during the outbreak of COVID-19. When we face severe COVID-19 cases, we need to think about more, especially co-infection. Older patients, having diabetes, hypertension are causes of severe COVID-19 cases [3,4]. Furthermore, patients with diabetes are also easily infected with pathogens [5]. Anyway, we should be aware of the co-infection of other respiratory pathogens in patients with SARS-CoV-2 infection. Different kinds of detection methods should be used to find out pathogens in the pandemic of SARS-CoV-2.

Declaration of competing interest

All authors declare no financial, potential personal or commercial conflict of interest.
  4 in total

1.  A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.

Authors:  Vincent J Munster; Marion Koopmans; Neeltje van Doremalen; Debby van Riel; Emmie de Wit
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

2.  Quantifying the risk of infectious diseases for people with diabetes.

Authors:  Baiju R Shah; Janet E Hux
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

3.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

4.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

  4 in total
  4 in total

1.  A case of neglected hepatorenal dysfunction during the COVID pandemic.

Authors:  Rama Chaudhry; Priyam Batra; Swati Khullar; E V Vinayraj; Lalit Dar; Dalim Kumar Baidya; Bikas Ranjan Ray; Rajeshwari Subramaniam
Journal:  Indian J Med Microbiol       Date:  2021-03-26       Impact factor: 0.985

Review 2.  The role of co-infections and secondary infections in patients with COVID-19.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Pneumonia (Nathan)       Date:  2021-04-25

3.  Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?

Authors:  Jorge A Sánchez-Duque; Juan Pablo Orozco-Hernández; Daniel S Marín-Medina; Aleksandar Cvetkovic-Vega; Telmo Raul Aveiro-Róbalo; Alvaro Mondragon-Cardona; Virgilio E Failoc-Rojas; Estefanía Gutiérrez-Ocampo; Rhuvi Villamizar-Peña; Juan F Henao-Martínez; Kovy Arteaga-Livias; Alfonso J Rodríguez-Morales
Journal:  J Med Virol       Date:  2020-06-24       Impact factor: 20.693

4.  SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East.

Authors:  Yu-Nong Gong; Kuo-Chien Tsao; Mei-Jen Hsiao; Chung-Guei Huang; Peng-Nien Huang; Po-Wei Huang; Kuo-Ming Lee; Yi-Chun Liu; Shu-Li Yang; Rei-Lin Kuo; Kuan-Fu Chen; Yen-Chin Liu; Sheng-Yu Huang; Hsing-I Huang; Ming-Tsan Liu; Ji-Rong Yang; Cheng-Hsun Chiu; Cheng-Ta Yang; Guang-Wu Chen; Shin-Ru Shih
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.